Molten Ventures Valuation
Is GROWL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GROWL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate GROWL's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate GROWL's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GROWL?
Key metric: As GROWL barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
What is GROWL's PB Ratio? | |
---|---|
PB Ratio | 0.5x |
Book | UK£1.20b |
Market Cap | UK£585.41m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 231.2x |
Enterprise Value/EBITDA | -23.5x |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does GROWL's PB Ratio compare to its peers?
Company | Forward PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.6x | ||
IPO IP Group | 0.4x | 139.0% | UK£432.8m |
ARIX Arix Bioscience | 0.7x | n/a | UK£176.5m |
OCI Oakley Capital Investments | 0.7x | n/a | UK£850.3m |
ORIT Octopus Renewables Infrastructure Trust | 0.7x | n/a | UK£390.6m |
GROWL Molten Ventures | 0.5x | 91.3% | UK£585.4m |
Price-To-Book vs Peers: GROWL is good value based on its Price-To-Book Ratio (0.5x) compared to the peer average (0.6x).
Price to Book Ratio vs Industry
How does GROWL's PB Ratio compare vs other companies in the GB Capital Markets Industry?
Price-To-Book vs Industry: GROWL is good value based on its Price-To-Book Ratio (0.5x) compared to the UK Capital Markets industry average (0.9x).
Price to Book Ratio vs Fair Ratio
What is GROWL's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | 0.5x |
Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate GROWL's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | UK£3.21 | UK£5.54 +72.5% | 13.5% | UK£6.54 | UK£4.59 | n/a | 5 |
Nov ’25 | UK£3.36 | UK£5.45 +62.2% | 14.0% | UK£6.54 | UK£4.71 | n/a | 4 |
Oct ’25 | UK£4.00 | UK£5.69 +42.2% | 14.6% | UK£6.62 | UK£4.71 | n/a | 5 |
Sep ’25 | UK£4.11 | UK£5.40 +31.5% | 23.2% | UK£6.62 | UK£3.30 | n/a | 5 |
Aug ’25 | UK£3.66 | UK£5.32 +45.3% | 24.5% | UK£6.62 | UK£3.30 | n/a | 5 |
Jul ’25 | UK£3.58 | UK£5.33 +48.9% | 24.2% | UK£6.62 | UK£3.30 | n/a | 5 |
Jun ’25 | UK£3.33 | UK£5.33 +60.4% | 24.2% | UK£6.61 | UK£3.30 | n/a | 5 |
May ’25 | UK£2.82 | UK£5.33 +89.1% | 24.2% | UK£6.61 | UK£3.30 | n/a | 5 |
Apr ’25 | UK£2.36 | UK£5.58 +136.2% | 24.3% | UK£6.65 | UK£3.30 | n/a | 4 |
Mar ’25 | UK£2.68 | UK£5.48 +104.4% | 30.4% | UK£7.35 | UK£3.30 | n/a | 3 |
Feb ’25 | UK£2.22 | UK£5.48 +147.0% | 30.4% | UK£7.35 | UK£3.30 | n/a | 3 |
Jan ’25 | UK£2.77 | UK£6.08 +119.9% | 21.1% | UK£7.35 | UK£4.30 | n/a | 4 |
Dec ’24 | UK£2.70 | UK£6.50 +140.6% | 21.8% | UK£8.15 | UK£4.30 | n/a | 5 |
Nov ’24 | UK£2.28 | UK£6.60 +189.0% | 22.6% | UK£8.15 | UK£4.30 | UK£3.36 | 5 |
Oct ’24 | UK£2.31 | UK£6.60 +186.0% | 22.6% | UK£8.15 | UK£4.30 | UK£4.00 | 5 |
Sep ’24 | UK£2.42 | UK£6.60 +173.0% | 22.6% | UK£8.15 | UK£4.30 | UK£4.11 | 5 |
Aug ’24 | UK£2.62 | UK£6.60 +151.5% | 22.6% | UK£8.15 | UK£4.30 | UK£3.66 | 5 |
Jul ’24 | UK£2.67 | UK£7.61 +185.1% | 17.4% | UK£9.00 | UK£5.43 | UK£3.58 | 4 |
Jun ’24 | UK£2.99 | UK£8.08 +169.7% | 7.7% | UK£9.00 | UK£7.28 | UK£3.33 | 4 |
May ’24 | UK£2.79 | UK£7.86 +181.8% | 8.9% | UK£9.00 | UK£7.28 | UK£2.82 | 4 |
Apr ’24 | UK£2.76 | UK£7.93 +187.1% | 8.9% | UK£9.00 | UK£7.28 | UK£2.36 | 4 |
Mar ’24 | UK£3.78 | UK£7.93 +109.9% | 8.9% | UK£9.00 | UK£7.28 | UK£2.68 | 4 |
Feb ’24 | UK£3.53 | UK£7.93 +124.5% | 8.9% | UK£9.00 | UK£7.28 | UK£2.22 | 4 |
Jan ’24 | UK£3.56 | UK£8.65 +143.3% | 12.5% | UK£10.20 | UK£7.28 | UK£2.77 | 4 |
Dec ’23 | UK£4.21 | UK£8.98 +113.4% | 8.6% | UK£10.20 | UK£8.12 | UK£2.70 | 4 |
Nov ’23 | UK£3.44 | UK£9.23 +168.3% | 6.4% | UK£10.20 | UK£8.61 | UK£2.28 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
BFF Bank
€1.6b
Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.
0RON
€8.77
7D
-1.5%
1Y
-16.0%
Exor
€20.0b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
0RKY
€93.80
7D
-0.1%
1Y
5.2%
Man Group
UK£2.4b
Man Group Limited is a publicly owned investment manager.
EMGL
UK£2.09
7D
1.2%
1Y
-0.4%